T2 Biosystems T2SARS-CoV-2™ Panel Detects Omicron Variant

LEXINGTON, Mass., Dec. 01, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO),  a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel detects the Omicron COVID-19 variant (B.1.1.529).

Click here to view original post